SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-029112
Filing Date
2023-08-11
Accepted
2023-08-11 17:05:45
Documents
57
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20230630.htm   iXBRL 10-Q 830954
2 EX-10.1 amendmentno3totheamendedan.htm EX-10.1 6286
3 EX-31.1 a2023q2-exhibit311.htm EX-31.1 12548
4 EX-31.2 a2023q2-exhibit312.htm EX-31.2 12542
5 EX-32.1 a2023q2-exhibit321.htm EX-32.1 6875
  Complete submission text file 0001628280-23-029112.txt   4148051

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20230630.xsd EX-101.SCH 34287
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20230630_cal.xml EX-101.CAL 51027
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20230630_def.xml EX-101.DEF 132401
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20230630_lab.xml EX-101.LAB 392336
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20230630_pre.xml EX-101.PRE 257690
51 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20230630_htm.xml XML 412813
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 231165099
SIC: 2834 Pharmaceutical Preparations